BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37436378)

  • 21. Identification of Potential Key Genes and Pathways in Enzalutamide-Resistant Prostate Cancer Cell Lines: A Bioinformatics Analysis with Data from the Gene Expression Omnibus (GEO) Database.
    Zheng L; Dou X; Ma X; Qu W; Tang X
    Biomed Res Int; 2020; 2020():8341097. PubMed ID: 32724813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Weighted Gene Co-Expression Network Analysis Identifies Hub Genes Associated with Occurrence and Prognosis of Oral Squamous Cell Carcinoma.
    Ge Y; Li W; Ni Q; He Y; Chu J; Wei P
    Med Sci Monit; 2019 Sep; 25():7272-7288. PubMed ID: 31562292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
    Li F; Guo P; Dong K; Guo P; Wang H; Lv X
    J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
    [No Abstract]   [Full Text] [Related]  

  • 24. Screening and identification of key biomarkers of papillary renal cell carcinoma by bioinformatic analysis.
    Xu Y; Kong D; Li Z; Qian L; Li J; Zou C
    PLoS One; 2021; 16(8):e0254868. PubMed ID: 34358255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Hub Gene GRIN1 Correlated with Histological Grade and Prognosis of Glioma by Weighted Gene Coexpression Network Analysis.
    Yang A; Wang X; Hu Y; Shang C; Hong Y
    Biomed Res Int; 2021; 2021():4542995. PubMed ID: 34840971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of hub genes predicting the development of prostate cancer from benign prostate hyperplasia and analyzing their clinical value in prostate cancer by bioinformatic analysis.
    Chen X; Ma J; Xu C; Wang L; Yao Y; Wang X; Zi T; Bian C; Wu D; Wu G
    Discov Oncol; 2022 Jun; 13(1):54. PubMed ID: 35768705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of hub genes and pathways in adrenocortical carcinoma by integrated bioinformatic analysis.
    Guo J; Gu Y; Ma X; Zhang L; Li H; Yan Z; Han Y; Xie L; Guo X
    J Cell Mol Med; 2020 Apr; 24(8):4428-4438. PubMed ID: 32147961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics.
    Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S
    Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening Key Genes and Biological Pathways in Nasopharyngeal Carcinoma by Integrated Bioinformatics Analysis.
    Tai J; Park J; Han M; Kim TH
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrated Analysis Revealed Prognostic Factors for Prostate Cancer Patients.
    Che H; Liu Y; Zhang M; Meng J; Feng X; Zhou J; Liang C
    Med Sci Monit; 2019 Dec; 25():9991-10007. PubMed ID: 31876269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Potential Hub Genes and Therapeutic Drugs in Malignant Pleural Mesothelioma by Integrated Bioinformatics Analysis.
    Zhang X; Yang L; Chen W; Kong M
    Oncol Res Treat; 2020; 43(12):656-671. PubMed ID: 33032291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathway crosstalk analysis in prostate cancer based on protein-protein network data.
    Li HY; Jin N; Han YP; Jin XF
    Neoplasma; 2017; 64(1):22-31. PubMed ID: 27881001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying the mRNAs associated with Bladder cancer recurrence.
    Cao H; Cheng L; Yu J; Zhang Z; Luo Z; Chen D
    Cancer Biomark; 2020; 28(4):429-437. PubMed ID: 32390597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis.
    Bi N; Sun Y; Lei S; Zeng Z; Zhang Y; Sun C; Yu C
    Oncol Rep; 2020 Aug; 44(2):611-627. PubMed ID: 32627011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SOX9 and IL1A as the Potential Gene Biomarkers of the Oral Cancer.
    Li T; Cheng D; Guo J; Chen H; Zhang S; Bao Y
    Comb Chem High Throughput Screen; 2023; 26(8):1461-1479. PubMed ID: 35762542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Potential miRNAs Biomarkers for High-Grade Prostate Cancer by Integrated Bioinformatics Analysis.
    Foj L; Filella X
    Pathol Oncol Res; 2019 Oct; 25(4):1445-1456. PubMed ID: 30367364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of vital modules and genes associated with heart failure based on weighted gene coexpression network analysis.
    Bian W; Wang Z; Li X; Jiang XX; Zhang H; Liu Z; Zhang DM
    ESC Heart Fail; 2022 Apr; 9(2):1370-1379. PubMed ID: 35128826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioinformatics analysis identified hub genes in prostate cancer tumorigenesis and metastasis.
    Gu P; Yang D; Zhu J; Zhang M; He X
    Math Biosci Eng; 2021 Apr; 18(4):3180-3196. PubMed ID: 34198380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
    Li J; Liu X; Cui Z; Han G
    Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.